Apogee Therapeutics (APGE) Times Interest Earned (2022 - 2026)
Apogee Therapeutics' (APGE) quarterly Times Interest Earned came in at -$0.31 in Q1 2026, up 99.98% year-on-year from -$0.15 in Q1 2025, and up 14.52% on a QoQ basis from -$0.36 in Q4 2025.
Apogee Therapeutics (APGE) Times Interest Earned (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of Times Interest Earned data on file, last reported at -$0.31 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 99.98% year-over-year to -$0.31 in Q1 2026; TTM through Mar 2026 was -$1.14, a 99.98% increase from a year earlier, with the FY2025 full-year figure at -$1.32, up 53.65% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.31, up from -$0.36 in the prior quarter.
- Over the last five years, Times Interest Earned for APGE reached as high as -$0.31 in Q1 2026 and fell as low as -$1603.7 in Q1 2025.
- Historically, Times Interest Earned has averaged -$262.6 across 5 years, with a median of -$1.45 in 2025.
- Across the five-year window, Times Interest Earned slumped 485832.35% in 2025 and soared 99.98% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$2.11 in 2022, then surged by 41.64% to -$1.23 in 2023, then fell by 0.2% to -$1.23 in 2024, then surged by 70.73% to -$0.36 in 2025, then gained by 14.52% to -$0.31 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.31 in Q1 2026, -$0.36 in Q4 2025, and -$1.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Apogee Therapeutics | 9.35 Bn | 8.29 Bn | - | -0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.31 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -1.62 |
| Jun 30, 2025 | -1.28 |
| Mar 31, 2025 | -1,603.66 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | -569.91 |
| Jun 30, 2024 | -950.66 |
| Mar 31, 2024 | -0.33 |
| Dec 31, 2023 | -1.23 |
| Sep 30, 2023 | -18.45 |
| Dec 31, 2022 | -2.11 |